Inventia Skin is a Sydney-based start-up on a mission to revolutionise wound repair by developing Ligō, a skin printing robot. It  delivers rapid and precise regenerative cellular therapy products directly onto a wound and could help to treat difficult to heal skin burns. 

A number of partners - high profile scientists and physicians - are lending their expertise to the project, including world renowned burns surgeon Professor Fiona Wood, and leading bioprinting researcher, Professor Gordon Wallace. The partnership will endeavour to print a patient's own cells, embedded in an optimised matrix material, directly onto a wound site to accelerate and improve healing after skin injury.

The project was awarded $1M through our BioMedTech Horizons program, an initiative of the Medical Research Future Fund.  

MTPConnect hosts Caroline Duell and Elizabeth Stares chat to Inventia Life Science’s CEO Dr Julio Ribeiro and CTO Dr Aidan O'Mahony about their expanding company, new manufacturing premises, an upcoming clinical trial in 2023 and nomination for a KUKA Innovation Award 2022.